Tailoring Oncolytic Viruses for the Treatment of Pancreatic Cancer

Tailoring Oncolytic Viruses for the Treatment of Pancreatic Cancer

Pancreatic cancer (PC) is a highly aggressive disease with unmet therapeutic needs. Recent advances in the use of oncolytic viruses (OVs) as cancer therapeutic agents bring new hope to fight the notorious disease that is PC. Although OVs have shown promising results in certain cancers, some tumors r...

Full description

Bibliographic Details
Main Author:	Wedge, Marie-Ève
Other Authors:	Bell, John
Format:	Others
Language:	en
Published:	Université d'Ottawa / University of Ottawa 2020
Subjects:	Oncolytic virus Pancreatic cancer Extracellular vesicles microRNA Synthetic lethality Bystander effect
Online Access:	http://hdl.handle.net/10393/40384 http://dx.doi.org/10.20381/ruor-24617

Similar Items

The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer
by: Scott D. Haller, et al.
Published: (2020-11-01)

Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma
by: Qingqing Li, et al.
Published: (2019-12-01)

Blocking the RNA Interference Pathway Improves Oncolytic Virus Therapy
by: Aitken, Amelia
Published: (2017)

Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells
by: Jakub Godlewski, et al.
Published: (2021-03-01)

Implications of MicroRNAs in Oncolytic Virotherapy
by: Xavier Bofill-De Ros, et al.
Published: (2017-07-01)

Coxsackievirus B3—Its Potential as an Oncolytic Virus
by: Anja Geisler, et al.
Published: (2021-04-01)

Extracellular Vesicles Deliver Host and Virus RNA and Regulate Innate Immune Response
by: Takahisa Kouwaki, et al.
Published: (2017-03-01)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
by: Pascal Buijs, et al.
Published: (2015-06-01)

Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA
by: Noura B. Elsedawy, et al.
Published: (2020-06-01)

MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model
by: Yogesh R. Suryawanshi, et al.
Published: (2021-12-01)

Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications
by: Moritz Reese, et al.
Published: (2021-09-01)

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability
by: Edward M. Kennedy, et al.
Published: (2020-09-01)

Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions
by: Molly C. Holbrook, et al.
Published: (2021-03-01)

Extracellular Vesicles-Mimetic Encapsulation Improves Oncolytic Viro-Immunotherapy in Tumors With Low Coxsackie and Adenovirus Receptor
by: Yonghui Zhang, et al.
Published: (2020-09-01)

Trash or Treasure: extracellular microRNAs and cell-to-cell communication
by: Nobuyoshi eKosaka, et al.
Published: (2013-09-01)

microRNA in Extracellular Vesicles Released by Damaged Podocytes Promote Apoptosis of Renal Tubular Epithelial Cells
by: Jin Seok Jeon, et al.
Published: (2020-06-01)

Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320
by: Francesca Pontis, et al.
Published: (2021-07-01)

Oncolytic Virotherapy with Myxoma Virus
by: Masmudur M. Rahman, et al.
Published: (2020-01-01)

Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers
by: Bolni Marius Nagalo, et al.
Published: (2020-09-01)

Impact of Zika Virus Infection on Human Neural Stem Cell MicroRNA Signatures
by: Denna Tabari, et al.
Published: (2020-10-01)

A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer
by: Christopher J. LaRocca, et al.
Published: (2018-11-01)

Distinct miRNA Profile of Cellular and Extracellular Vesicles Released from Chicken Tracheal Cells Following Avian Influenza Virus Infection
by: Kelsey O’Dowd, et al.
Published: (2020-08-01)

Methodological Approaches to Study Extracellular Vesicle miRNAs in Epstein–Barr Virus-Associated Cancers
by: Li Sun, et al.
Published: (2018-09-01)

Oncolytic viral therapy for pancreatic cancer: current research and future directions
by: Ady JW, et al.
Published: (2014-02-01)

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
by: Yoshiki Hirooka, et al.
Published: (2018-05-01)

Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01)

Tumor Restrictions to Oncolytic Virus
by: Markus Vähä-Koskela, et al.
Published: (2014-04-01)

Exogenous loading of miRNAs into small extracellular vesicles
by: Ricardo C. deAbreu, et al.
Published: (2021-08-01)

Cross-talk between cancer cells and their neighbors via miRNA in extracellular vesicles: an emerging player in cancer metastasis
by: Akiko Kogure, et al.
Published: (2019-01-01)

Red Blood Cells as Potential Repositories of MicroRNAs in the Circulatory System
by: Liping Sun, et al.
Published: (2020-06-01)

Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types
by: Guduric-Fuchs Jasenka, et al.
Published: (2012-08-01)

Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesis
by: Yu Fujita, et al.
Published: (2015-11-01)

Biogenesis, Stabilization, and Transport of microRNAs in Kidney Health and Disease
by: Melissa J. Thomas, et al.
Published: (2018-11-01)

Mechanistic and Therapeutic Insights of Macrophage MicroRNA in Atherosclerosis
by: Nguyen, My-Anh
Published: (2019)

Parasitic Helminth-Derived microRNAs and Extracellular Vesicle Cargos as Biomarkers for Helminthic Infections
by: Yi Mu, et al.
Published: (2021-06-01)

Oncolytic virus immunotherapy: future prospects for oncology
by: Junaid Raja, et al.
Published: (2018-12-01)

Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens
by: Tereza Brachtlova, et al.
Published: (2018-11-01)

Oncolytic virotherapy in hepato‐bilio‐pancreatic cancer: The key to breaking the log jam?
by: Yuwei Li, et al.
Published: (2020-05-01)

Developing an Oncolytic Prime-Boost Vaccine Targeting the Tumour Associated Antigen Mesothelin for the Treatment of Pancreatic Cancer
by: Baxter, Katherine Elizabeth
Published: (2020)

The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
by: Ibrahim Ragab Eissa, et al.
Published: (2018-09-01)